BIS

Fund Description
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index.
Fund Profile
Fund Name ProShares UltraShort Nasdaq Biotechnology
Fund Exchange Ticker BIS
Fund Sponsor ProShares
Fund ISIN US74347B7890
Net Expense Ratio 0.95 %
Fund Inception Date 7 April 2010
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Leveraged / Inverse
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Nasdaq Biotech Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Inverse (-2x)
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 18 January 2019
Asset Under Management 26.76 Million (USD)
1 Month Total Return -23.45 %
Year To Date Return -24.63 %
1 Year Total Return -13.46 %
3 Year Annualized Total Return -24.96 %
NAV 17.43
Share Outstanding 1,535,000
Top 10 Holdings (18 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
UNITED STATES TREASURY BILL BILL
Net Other Assets / Cash CASH
UNITED STATES TREASURY BILL BILL
UNITED STATES TREASURY BILL BILL
UNITED STATES TREASURY BILL BILL
UNITED STATES TREASURY BILL BILL
UNITED STATES TREASURY BILL BILL
UNITED STATES TREASURY BILL BILL
UNITED STATES TREASURY BILL BILL
UNITED STATES TREASURY BILL BILL